[Lymphosarcoma of the oropharynx and nasopharynx in children].
From 1983 to 1989, 22 patients aged 3 to 15 years with oro- and rhinopharyngeal lymphosarcomas were under observation. This number accounted for 10% of the total children's population with the same disease, with the observation period being the same. As a result of the examination, stage II was diagnosed in 13, stage III in 5, and stage IV in 4 patients. All the patients received chemo- and radiotherapy for 6-18 months. The relapse-free survival amounted to 50 months on the average, the total one to 52 months. It is stressed that early diagnosis and adequate therapy allow the cure of the majority of children with oro- and rhinopharyngeal lymphosarcomas.
Gordina
G A
GA
Kiselev
A V
AV
Morozova
O V
OV
Lobanov
G V
GV
Gubin
A N
AN
Vinokurov
B K
BK
Koshechkina
N A
NA
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000401:mortality / Q000628:therapy; D009959:Oropharyngeal Neoplasms / Q000401:mortality / Q000628:therapy; D013997:Time Factors
Limfosarkoma roto- i nosoglotki u deteĭ.